Back to search

Biomarker Conservation in Primary and Metastatic Epithelial Ovarian Cancer

Data up to Jan 2025

Published2000
Citations46
References30

Total Citations Per Year

Abstract

References (30)

The Clonal Evolution of Tumor Cell Populations

1976 • 6,310 citations

A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

1979 • 1,331 citations

Chromosome Studies on Normal and Leukemic Human Leukocytes

1960 • 1,051 citations

Zur Frage der Entstehung maligner Tumoren

1914 • 796 citations

X‐CHROMOSOME INACTIVATION AND DEVELOPMENTAL PATTERNS IN MAMMALS

1972 • 657 citations

Rationale for the use of alternating non-cross-resistant chemotherapy.

1982 • 545 citations

Tumor angiogenesis in advanced stage ovarian carcinoma.

1995 • 395 citations

Vascular permeability factor gene expression in normal and neoplastic human ovaries.

1994 • 259 citations

Prognostic factors in ovarian cancer.

1991 • 192 citations

Clonal Origin of Epithelial Ovarian Carcinoma: Analysis by Loss of Heterozygosity, p53 Mutation, and X-Chromosome Inactivation

1992 • 157 citations

Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas

1996 • 132 citations

The Expression of Vascular Endothelial Growth Factor and Transforming Growth Factor-β Associates With Angiogenesis in Epithelial Ovarian Cancer

1997 • 102 citations

Prognostic factors in ovarian cancer

1998 • 87 citations

Immunophenotype of Ovarian Cancer as Predictor of Clinical Outcome: Evaluation at Primary Surgery and Second-Look Procedure

1998 • 63 citations

The molecular basis of ovarian cancer

1995 • 57 citations

Flow cytometric analysis of lymph node metastases in advanced ovarian cancer: Clinical and biologic significance

1997 • 34 citations

Overexpression and relationships of HER-2/neu, epidermal growth factor receptor, p53, Ki-67, and tumor necrosis factor alpha in epithelial ovarian cancer.

1996 • 33 citations

Ovarian carcinoma heterogeneity as demonstrated by DNA ploidy

1993 • 32 citations

Molecular genetic evidence for unifocal origin of advanced epithelial ovarian cancer and for minor clonal divergence

1995 • 32 citations

DNA Index Reflects the Biological Behavior of Ovarian Carcinoma Stage I–IIa

1996 • 32 citations

Tumor heterogeneity and in vitro chemosensitivity testing in ovarian cancer

1997 • 30 citations

The Genetic Basis of Resistance to Cancer Chemotherapy

1995 • 30 citations

Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma

1994 • 21 citations

Elevated Serum ICTP Concentrations Reflect Poor Prognosis in Patients with Ovarian Carcinoma

1995 • 16 citations

p53 expression, DNA content and cell proliferation in primary and synchronous metastatic lesions from ovarian surface epithelial-stromal tumours

1996 • 9 citations

Concordance of DNA Ploidy Pattern as Measured by Flow Cytometry in Primary, Metastatic, and Persistent Ovarian Carcinoma

1996 • 5 citations

Detection of Cellular Heterogeneity by DNA Ploidy, 17 Chromosome, and p53 Gene in Primary Carcinoma and Metastasis in a Case of Ovarian Cancer

1996 • 5 citations

Intratumor heterogeneity of morphometric and stereologic variables in primary ovarian tumors and their omental metastatic deposits.

1997 • 3 citations

Chemotherapy changes the DNA ploidy in ovarian cancer

1995 • 2 citations

Minimizing drug resistance. The somatic mutation model and gestational trophoblastic neoplasia.

1987 • 2 citations

Cited By (0)

Loading...
Biomarker Conservation in Primary and Metastatic Epithelial Ovarian Cancer (2000) – Gynecologic Oncology | Metascience Observatory Explorer